Genetic variations in SEMA3A have been reported to be associated with severe early onset obesity owing to disrupted SEMA3A signaling in pro-opiomelanocortin (POMC)-expressing anorexigenic neurons [34]. The gene discussed is POMC; the disease is obesity disorder.